NCT07353931: Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
- State
- Under way
- Phase
- Phase 3
- People
- 900 planned
- Started
- 9 Feb 2026
- Primary completion
- Mar 2028
- Arms
- Eloralintide (YOA1), Eloralintide (YOA2)
- Results
- None posted
- 21 Jan 2026: Trial registered
- 9 Feb 2026: Trial started